STAT4-mediated down-regulation of miR-3619-5p facilitates stomach adenocarcinoma by modulating TBC1D10B

References

• Wang Z, Wang K, Dang Y, Ouyang X, Zhang F, Wang W, Wang L, Huang Q. Evaluation of the expression and clinical value of lncRNA AC010761.9 in human gastric adenocarcinoma. World J Surg Oncol. 2018;16:40. doi:10.1186/s12957-017-1289-y.
   PubMed Web of Science ®Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. doi:10.3322/caac.20138.
   PubMed Web of Science ®Google Scholar
• Ma Y, Liu L, Yan F, Wei W, Deng J, Sun J. Enhanced expression of long non-coding RNA NEAT1 is associated with the progression of gastric adenocarcinomas. World J Surg Oncol. 2016;14:41. doi:10.1186/s12957-016-0799-3.
   PubMed Web of Science ®Google Scholar
• Gu J, Li Y, Fan L, Zhao Q, Tan B, Hua K, Wu G. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma. Oncotarget. 2017;8:49201–49216. doi:10.18632/oncotarget.17329.
   PubMedGoogle Scholar
• Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141:1202–1207. doi:10.1016/j.jaci.2017.08.034.
   PubMed Web of Science ®Google Scholar
• Wu W. MicroRNA, noise, and gene expression regulation. Methods Mol Biol (Clifton, NJ). 2018;1699:91–96.
   PubMedGoogle Scholar
• Backes C, Meese E, Keller A. Specific miRNA disease biomarkers in blood, serum and plasma: challenges and prospects. Mol Diagn Ther. 2016;20:509–518. doi:10.1007/s40291-016-0221-4.
   PubMed Web of Science ®Google Scholar
• Bernardo BC, Ooi JY, Lin RC, McMullen JR. miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart. Future Med Chem. 2015;7:1771–1792. doi:10.4155/fmc.15.107.
   PubMed Web of Science ®Google Scholar
• Cao T, Zhen XC. Dysregulation of miRNA and its potential therapeutic application in schizophrenia. CNS Neurosci Ther. 2018;24:586–597. doi:10.1111/cns.12840.
   PubMed Web of Science ®Google Scholar
• Tan YL, Bai ZG, Zou WL, Ma XM, Wang TT, Guo W, Liu J, Li JS, Jie Y, Zang YJ, et al. miR-744 is a potential prognostic marker in patients with hepatocellular carcinoma. Clin Res Hepatol Gastroenterol. 2015;39:359–365. doi:10.1016/j.clinre.2014.09.010.
   PubMed Web of Science ®Google Scholar
• Fang Z, Yin S, Sun R, Zhang S, Fu M, Wu Y, Zhang T, Khaliq J, Li Y. miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1. Mol Cancer. 2017;16:139. doi:10.1186/s12943-017-0708-6.
   PubMed Web of Science ®Google Scholar
• Shi Y, Shi H, Zhang B, Yan Y, Han X, Jiang W, Qian H, Xu W. miR-373 suppresses gastric cancer metastasis by downregulating vimentin. Mol Med Rep. 2018;17:4027–4034. doi:10.3892/mmr.2017.8291.
   PubMed Web of Science ®Google Scholar
• Qiu X, Zhu H, Liu S, Tao G, Jin J, Chu H, Wang M, Tong N, Gong W, Zhao Q, et al. Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer. J Gastroenterol Hepatol. 2017;32:819–827. doi:10.1111/jgh.13533.
   PubMed Web of Science ®Google Scholar
• Huang H, Liao W, Zhu X, Liu H, Cai L. Knockdown of long noncoding RNA GHET1 inhibits cell activation of gastric cancer. Biomed Pharmacother. 2017;92:562–568. doi:10.1016/j.biopha.2017.05.088.
   PubMed Web of Science ®Google Scholar
• Niu X, Liu S, Jia L, Chen J. Role of MiR-3619-5p in beta-catenin-mediated non-small cell lung cancer growth and invasion. Cel. Physiol Biochem. 2015;37:1527–1536. doi:10.1159/000438520.
   PubMedGoogle Scholar
• Zhang M, Luo H, Hui L. MiR-3619-5p hampers proliferation and cisplatin resistance in cutaneous squamous-cell carcinoma via KPNA4. Biochem Biophys Res Commun. 2019;513:419–425. doi:10.1016/j.bbrc.2019.03.203.
   PubMed Web of Science ®Google Scholar
• Gonzales-van Horn SR, Estrada LD, van Oers NS, Farrar JD. STAT4-mediated transcriptional repression of the IL5 gene in human memory Th2 cells. Eur J Immunol. 2016;46:1504–1510. doi:10.1002/eji.201546050.
   PubMed Web of Science ®Google Scholar
• Jin K, Zhao W, Xie X, Pan Y, Wang K, Zhang H. MiR-520b restrains cell growth by targeting HDAC4 in lung cancer. Thoracic Cancer. 2018;9:1249–1254. doi:10.1111/1759-7714.12825.
   PubMed Web of Science ®Google Scholar
• Li Y, Wen X, Wang L, Sun X, Ma H, Fu Z, Li L. LncRNA ZEB1-AS1 predicts unfavorable prognosis in gastric cancer. Surg Oncol. 2017;26:527–534. doi:10.1016/j.suronc.2017.09.008.
   PubMed Web of Science ®Google Scholar
• Sanjay S, Girish C. Role of miRNA and its potential as a novel diagnostic biomarker in drug-induced liver injury. Eur J Clin Pharmacol. 2017;73:399–407. doi:10.1007/s00228-016-2183-1.
   PubMed Web of Science ®Google Scholar
• Ma Y. The Challenge of microRNA as a Biomarker of Epilepsy. Curr Neuropharmacol. 2018;16:37–42. doi:10.2174/1570159X15666170703102410.
   PubMed Web of Science ®Google Scholar
• Bekris LM, Leverenz JB. The biomarker and therapeutic potential of miRNA in Alzheimer’s disease. Neurodegener Dis Manag. 2015;5:61–74. doi:10.2217/nmt.14.52.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Miao S, Han X, Li C, Zhang M, Cui K, Xiong T, Chen Z, Wang C, Xu H. MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting beta-catenin and CDK2 and activating p21. Cell Death Dis. 2018;9:960. doi:10.1038/s41419-018-0986-y.
   PubMed Web of Science ®Google Scholar
• Yan G, Su Y, Ma Z, Yu L, Chen N. Long noncoding RNA LINC00202 promotes tumor progression by sponging miR-3619-5p in retinoblastoma. Cell Struct Funct. 2019;44:51–60. doi:10.1247/csf.18033.
   PubMed Web of Science ®Google Scholar
• Liu Z, Kang Z, Dai Y, Zheng H, Wang Y. Long non-coding RNA LINC00342 promotes growth of infantile hemangioma by sponging miR-3619-5p from HDGF. Am J Physiol Heart Circ Physiol. 2019. doi:10.1152/ajpheart.00188.2019.
   Web of Science ®Google Scholar
• Tan A, Li Q, Chen L. CircZFR promotes hepatocellular carcinoma progression through regulating miR-3619-5p/CTNNB1 axis and activating Wnt/beta-catenin pathway. Arch Biochem Biophys. 2019;661:196–202. doi:10.1016/j.abb.2018.11.020.
   PubMed Web of Science ®Google Scholar